TEL AVIV STOCK EXCHANGE · TEVA
-0.42% · -$0.1700 · Vol Not reported
Pre-market · updated 04:23:26 ET
Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd

Pharmaceuticals
$40.05
Card
Relationship Map

Follow $TEVA

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $TEVA by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Analyst data unavailable at compute time
TEVA
Teva Pharmaceutical Industries Ltd
Thu Sep 24 · last completed session · Pre-market · regular session opens 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

64/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Thu Sep 24 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is TEVA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading TEVA catalysts
About Teva Pharmaceutical Industries Ltd
PHARMACEUTICAL PREPARATIONS
Listed since
1982
Employees
33K
Country
IL

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$40.22
Last session
Day high
$40.22
Last session
Day low
$40.22
Last session
Previous close
$40.22
52W high
$40.22
-0.42% from high
52W low
$18.34
99% of range
Market cap
$46.9B
P/E
93.14×
EPS
$0.4300
Beta
0.04
Shares out
1.2B
Avg volume
5.1M
VWAP
$40.22
Last session
Price history computed in-house
1W
+2.74%
1M
+5.62%
3M
+20.60%
1Y
+118.14%
YTD
+28.32%
SMA 50 $35.96 · above
SMA 200 $33.38 · above
52W position 99%

TEVA overview

Loading financial statements
Loading TEVA Form 4 filings
Public disclosures

Congress activity in TEVA

Teva Pharmaceutical Industries Limited American Depositary Shares · Transaction Mar 30, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000

Official filing ↗

Teva Pharmaceutical Industries limited American depositary Shares · Transaction Nov 13, 2020 · Filed Dec 2, 2020 · $15,001 to $50,000

Official filing ↗

Teva Pharmaceutical Industries limited American depositary Shares · Transaction Jan 30, 2017 · Filed Feb 9, 2017 · $1,001 to $15,000

Official filing ↗
Federal contracts

TEVA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TEVA in this window.
Lobbying spend

TEVA lobbying filings, year to date.

Registered lobbying filings matched to Teva Pharmaceutical Industries Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TEVA in this window.
Loading news for TEVA
Analyst ratings
Sovereign unlock shows live analyst consensus for TEVA.
Options
Sovereign unlock shows live options positioning for TEVA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.